AIMEDBIO

IR

Disclosure

64 posts
NO. Title Date Author
64 Semi-annual Report (2026.06) 2026-08-12 에임드바이오
63 [Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) 2026-08-10 에임드바이오
62 [Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) 2026-07-22 에임드바이오
61 Report on the Appointment, Dismissal or Early Retirement of Independent Directors 2026-07-16 에임드바이오
60 Outcomes of Extraordinary General Meeting of Shareholders 2026-07-16 에임드바이오
59 [Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) 2026-07-15 에임드바이오
58 Announcement of convocation of general meeting of shareholders 2026-07-01 에임드바이오
57 Notice on Investor Relations 2026-06-30 에임드바이오
56 Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 마일스톤 기술료 수령) 2026-06-26 에임드바이오
55 Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) 2026-06-26 에임드바이오
1 2 3 4 5